Our Science

Publications and Presentations

search
Date
Title
October 2019
Successful Treatment of a Patient with Retroperitoneal Abscess caused by Candida krusei with the Investigational Agent, Ibrexafungerp (formerly SCY-078): A Case Report from the FURI study GR Thompson, David Angulo
TIMM 2019
June 2019
Penetration of Ibrexafungerp (formerly SCY-078) versus Micafungin at the Site of Infection in an Intra-abdominal Candidiasis Mouse Model Annie Lee, Brendan Prideaux, Min Hee Lee, Matthew Zimmerman, Padmaja Paderua, Stephen A. Barat, David Angulo, David S. Perlin, Yanan Zhao
ASM Microbe 2019
June 2019
Efficacy of Ibrexafungerp (IBX, formerly SCY-078) in the Treatment of Candida auris Cutaneous Infection in a Guinea Pig Model M. Ghannoum, L. Long, C. Hager, K. Borroto-Esoda, S. Barat, and D. Angulo
ASM Microbe 2019
April 2019
Oral Ibrexafungerp (SCY-078) in Refractory Fungal Diseases Oliver A. Cornely MD, FECMM, FIDSA, FAAM, FACP
Consultant, Infectious Diseases
Director, European Mycology Excellence Center
University Hospital of Cologne
ECCMID 2019
April 2019
Successful Treatment of Two Patients with Candida auris Candidemia with the Investigational Agent, Oral Ibrexafungerp (formerly SCY-078), from the CARES Study D Juneja, O Singh, B Tarai, DA Angulo
ECCMID 2019
April 2019
Favourable Clinical Outcome of Two Patients with Candida spp. Spondylodiscitis treated with Oral Ibrexafungerp (formerly SCY-078) from the FURI Study Philipp Koehler, Oliver A. Cornerly, David Angulo
ECCMID 2019
April 2019
Use of Ibrexafungerp (formerly SCY-078) to Treat Severe Azole Refractory Esophageal Candidiasis. A Case Report from the Furi Study J Vazquez, Aprile Osborn, D Angulo
ECCMID 2019
April 2019
Penetration of Ibrexafungerp (formerly SCY-078) versus Micafungin at the Site of Infection in an Intra-abdominal Candidiasis Mouse Model Annie Lee, Brendan Prideaux, Min Hee Lee, Matthew Zimmerman, Padmaja Paderu, Stephen A. Barat, David Angulo, David S. Perlin, Yanan Zhao
ECCMID 2019
April 2019
Efficacy of Ibrexafungerp (formerly SCY-078) Against Pneumocystis Pneumonia in a Murine Therapeutic Model. Stephen A. Barat, Katyna Borroto-Esoda, David A. Angulo, Alan Ashbaugh, Melanie Cushion
ECCMID 2019
March 2019
Ibrexafungerp: Activity against Pneumocystis S. Barat
Superbugs and Superdrugs 2019
< PrevNext >